ICYMI: Reports of the arrival in the U.S. of a new superbug that is resistant to an antibiotic of last resort have set off alarm bells among public health officials. Northeastern professor Kim Lewis explains the new superbug, how worried we should be, and how it might be stopped.
A biology major in Northeastern’s Honors Program and a 2016 Presidential Global Fellow, Julie Hugunin plans to pursue an MD/PhD program to combine her clinical and research interests, informed by a holistic approach. “Northeastern is about putting yourself out there and being fearless,” she says.
Hospital-related staph infections are rampant, with hundreds of thousands being reported in the U.S. each year. Northeastern researcher Kim Lewis and his colleagues are at the forefront of developing new drugs to stop the trend.
Northeastern researcher Kim Lewis and his team have launched an all-out effort to find a cure for Lyme disease, which afflicts nearly 300,000 new people in the U.S. each year. Their efforts aim to bring relief to all patients, including those who suffer from a debilitating chronic version of the disease.
Assistant professor Javier Apfeld plumbs the cellular mechanisms driving the aging process in worms, uncovering insights that could increase our own longevity.
Northeastern University Distinguished Professor Kim Lewis has received a $1.5 million grant from the Steven & Alexandra Cohen Foundation to develop better treatments for Lyme disease.
When Slava Epstein first arrived in America, he had little more than his family, a smuggled cat, and an “enormous amount of data” from his research in Russia. In 2015, he was part of one of the world’s biggest scientific stories.
A deep read about Professor Slava Epstein’s research, discoveries, and painting skills.
Each year for the past seven years, Foreign Policy selected the leading Global Thinkers whose contributions and work have changed lives and are shaping the world.
Two professors – one from the biology department and the other from the chemistry and chemical biology department – have been awarded more than a half-million dollars to investigate the production of cancer drugs in Catharanthus roseus.